FDA Issues Warning for 2 Diabetes Drugs Linked to Increased Heart Failure Risk
Following the results of 2 clinical trials, the Food and Drug Administration has issued warnings for diabetes medications containing saxagliptin and alogliptin. These medications have been shown to increase the risk of heart failure, especially for those who already suffer from heart or kidney disease.
An FDA statement notes:
